This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The basis for the clinical analysis was intention to treat. The primary health outcome was the number of days in hospital for psychiatric problems over 24 months, recorded in a modified World Health Organization (WHO) Life Chart. The secondary outcome measures included: clinical status, assessed using the Comprehensive Psychiatric Rating Scale (CPRS); quality of life, assessed using the Lancashire Quality of Life Profile; unmet needs, recorded using the Camberwell Assessment of need; social disability, measured by the WHO Disability Assessment Schedule (DAS); and patient satisfaction assessed, using a self-reported questionnaire.
No comparability of the study groups was reported in the present study (details were reported elsewhere -see "Other Publications of Related Interest" below), although the authors stated that there was no difference between those patients who were included in the analysis and those who were excluded.
Effectiveness results
There was no statistically significant difference between the intensive and standard groups in terms of the following outcome measures: the hospital days over 24 months were 73.5 in the intensive group and 73.1 in the standard group (difference 0.4 days, 95% confidence interval, CI: -17.4 -18.1); the CPRS scores were 18.5 in the intensive group and 18.1 in the standard group (difference 0.4, 95% CI: -1.8 -2.7); the quality of life scores were 4.58 in the intensive group and 4.55 in the standard group (difference 0.04, 95% CI: -0.09 -0.16); the number of unmet needs was 1.84 in the intensive group and 2.13 in the standard group (difference -0.29, 95% CI: -0.68 -0.11); the mean DAS total scores were 1.10 in the intensive group and 1.13 in the standard group (difference -0.03, 95% CI: -0.16 -0.10); and the mean patient's satisfaction scores were 16.7 in the intensive group and 17.1 in the standard group (difference -0.3, 95% CI: -1.2 -0.5).
Clinical conclusions
The median two-year cost (90% range) was 15,912 (2,232 to 73,035) in the intensive group and 14,736 (1,001 to 62,180) in the standard group.
The estimated costs were not sensitive to variations carried out in the sensitivity analyses.
Synthesis of costs and benefits
A formal synthesis of the costs and benefits was not carried out, due to the lack of statistical significance in terms of both the effectiveness and the costs. The authors explored the relationship between the costs and length of hospitalisation. They found that psychiatric inpatient costs comprised almost half of the total costs of care for patients in both groups (47% for intensive care and 48% for standard care). Overall, there was no evidence that intensive care was more cost-effective than standard care, or vice versa.
